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The rates of mortality and morbidity from colorectal cancer (CRC) have been increasing exponentially in Japan, and CRC is considered a national problem that needs to be solved urgently. Identification of factors involved in the carcinogenesis and progression of CRC would help prevent the occurrence of CRC, as well as improve the clinical outcome of treatment of the disease. For the last ten years, several genome‐wide association studies (GWAS) have identified single nucleotide polymorphisms (SNP) intimately connected to the onset of CRC. Tomlinson *et al*. identified rs6983267 at 8q24.21 as the SNP most strongly connected to the onset of CRC.[1](#cas13391-bib-0001){ref-type="ref"}, [2](#cas13391-bib-0002){ref-type="ref"} Zanke *et al*.[3](#cas13391-bib-0003){ref-type="ref"} investigated 100k SNP in 7480 cases of CRC with double screening among different races and discovered SNP at 8q24 as well as one at 9q24. Brodelick *et al*.[4](#cas13391-bib-0004){ref-type="ref"} report the SNP rs4938827 at 18q21 located within the gene SMAD7 from among 550k SNP in 7473 cases of CRC. Tenesa *et al*.[5](#cas13391-bib-0005){ref-type="ref"} report the SNP rs3802842 at 11q23, rs7014346 at 8q24 and rs4939827 at 18q21. Table [1](#cas13391-tbl-0001){ref-type="table-wrap"} shows the data derived from previous GWAS on CRC,[1](#cas13391-bib-0001){ref-type="ref"}, [2](#cas13391-bib-0002){ref-type="ref"}, [4](#cas13391-bib-0004){ref-type="ref"}, [5](#cas13391-bib-0005){ref-type="ref"}, [6](#cas13391-bib-0006){ref-type="ref"}, [7](#cas13391-bib-0007){ref-type="ref"}, [8](#cas13391-bib-0008){ref-type="ref"}, [9](#cas13391-bib-0009){ref-type="ref"}, [10](#cas13391-bib-0010){ref-type="ref"}, [11](#cas13391-bib-0011){ref-type="ref"}, [12](#cas13391-bib-0012){ref-type="ref"}, [13](#cas13391-bib-0013){ref-type="ref"}, [14](#cas13391-bib-0014){ref-type="ref"}, [15](#cas13391-bib-0015){ref-type="ref"}, [16](#cas13391-bib-0016){ref-type="ref"}, [17](#cas13391-bib-0017){ref-type="ref"}, [18](#cas13391-bib-0018){ref-type="ref"}, [19](#cas13391-bib-0019){ref-type="ref"}, [20](#cas13391-bib-0020){ref-type="ref"}, [21](#cas13391-bib-0021){ref-type="ref"}, [22](#cas13391-bib-0022){ref-type="ref"}, [23](#cas13391-bib-0023){ref-type="ref"} which reveal that risky genetic polymorphisms are different among various populations. For example, in the 8q23--24 region, rs6983267 is a risk factor for CRC among Caucasians, Asians and Africans, rs7014346 and rs10505477 are risky only among Caucasians, and rs16892766 is a risk factor for those with Caucasian and African ancestry.[24](#cas13391-bib-0024){ref-type="ref"}

###### 

Summary of previously reported single nucleotide polymorphisms (SNP) associated with colorectal cancer

  SNP            Chromosome   Gene                                     Odds ratio   *P*‐value        Population                       First author    Journal              Year   Reference number
  -------------- ------------ ---------------------------------------- ------------ ---------------- -------------------------------- --------------- -------------------- ------ ------------------------------------------
  rs4939827      18q21        *SMAD7*                                  1.15         1.0 × 10(−12)    Caucasian                        Broderick P     *Nat Genet*          2007   [4](#cas13391-bib-0004){ref-type="ref"}
  rs6983267      8q24         *--*                                     1.17         3 × 10(−11)      European                         Tomlinson IP    *Nat Genet*          2007   [1](#cas13391-bib-0001){ref-type="ref"}
  rs4444235      14q22.2      *BMP4*                                   1.11         8.1 × 10(−10)    European                         Houlston RS     *Nat Genet*          2008   [6](#cas13391-bib-0006){ref-type="ref"}
  rs9929218      16q22.1      *CDH1*                                   0.91         1.2 × 10(−8)     European                         Houlston RS     *Nat Genet*          2008   [6](#cas13391-bib-0006){ref-type="ref"}
  rs10411210     19q13.1      *RHPN2*                                  0.87         4.6 × 10(−9)     European                         Houlston RS     *Nat Genet*          2008   [6](#cas13391-bib-0006){ref-type="ref"}
  rs961253       20p12.3      *--*                                     1.12         2.0 × 10(−10)    European                         Houlston RS     *Nat Genet*          2008   [6](#cas13391-bib-0006){ref-type="ref"}
  rs4779584      15q13        *CRAC1*                                  1.26         4.44 × 10(−14)   Ashkenazi Jews and Europeans     Jaeger E        *Nat Genet*          2008   [7](#cas13391-bib-0007){ref-type="ref"}
  rs3802842      11q23        *--*                                     1.1          5.8 × 10(−10)    European, Japanese, Israeli      Tenesa A        *Nat Genet*          2008   [5](#cas13391-bib-0005){ref-type="ref"}
  rs10795668     10p14        *--*                                     1.12         2.5 × 10(−13)    European                         Tomlinson IP    *Nat Genet*          2008   [2](#cas13391-bib-0002){ref-type="ref"}
  rs16892766     8q23.3       *EIF3H*                                  1.26         3.3 × 10(−18)    European                         Tomlinson IP    *Nat Genet*          2008   [2](#cas13391-bib-0002){ref-type="ref"}
  rs7136702      12q13.13     *--*                                     1.06         4.02 × 10(−8)    European                         Houlston RS     *Nat Genet*          2010   [8](#cas13391-bib-0008){ref-type="ref"}
  rs6687758      1q41         *--*                                     1.09         2.27 × 10(−9)    European                         Houlston RS     *Nat Genet*          2010   [8](#cas13391-bib-0008){ref-type="ref"}
  rs6691170      1q41         *--*                                     1.06         9.55 × 10(−10)   European                         Houlston RS     *Nat Genet*          2010   [8](#cas13391-bib-0008){ref-type="ref"}
  rs4925386      20q13.33     *LAMA5*                                  0.93         1.89 × 10(−10)   European                         Houlston RS     *Nat Genet*          2010   [8](#cas13391-bib-0008){ref-type="ref"}
  rs10936599     3q26         *MYNN*                                   0.93         3.39 × 10(−8)    European                         Houlston RS     *Nat Genet*          2010   [8](#cas13391-bib-0008){ref-type="ref"}
  rs7758229      6q26         *SLC22A3*                                1.28         7.92 × 10(−9)    Japanese and Korean              Cui R           *Gut*                2011   [9](#cas13391-bib-0009){ref-type="ref"}
  rs1957636      14q22        *BMP4*                                   1.084        3.93 × 10(−10)   Caucasian                        Tomlinson IP    *Plos Genet*         2011   [11](#cas13391-bib-0011){ref-type="ref"}
  rs11632715     15p          *GREM1*                                  1.116        2.30 × 10(−10)   Caucasian                        Tomlinson IP    *Plos Genet*         2011   [11](#cas13391-bib-0011){ref-type="ref"}
  rs16969681     15p          *GREM1*                                  1.181        5.33 × 10(−8)    Caucasian                        Tomlinson IP    *Plos Genet*         2011   [11](#cas13391-bib-0011){ref-type="ref"}
  rs4813802      20p12        *BMP2*                                   1.093        4.65 × 10(−11)   Caucasian                        Tomlinson IP    *Plos Genet*         2011   [11](#cas13391-bib-0011){ref-type="ref"}
  rs3824999      11q13.4      *POLD3*                                  1.08         3.65 × 10(−10)   European and Japanese            Dunlop MG       *Nat Genet*          2012   [10](#cas13391-bib-0010){ref-type="ref"}
  rs1321311      6p21         *CDKN1A*                                 1.1          1.14 × 10(−10)   European and Japanese            Dunlop MG       *Nat Genet*          2012   [10](#cas13391-bib-0010){ref-type="ref"}
  rs5934683      Xp22.2       *SHROOM2*                                1.07         7.30 × 10(−10)   European and Japanese            Dunlop MG       *Nat Genet*          2012   [10](#cas13391-bib-0010){ref-type="ref"}
  rs4813802      20p12        *BMP2*                                   1.18         7.3 × 10(−5)     Caucasian                        Peters U        *Hum Genet*          2012   [12](#cas13391-bib-0012){ref-type="ref"}
  rs2853668      5p33.15      *TERT‐CLPTM1L*                           0.85         1.9 × 10(−4)     Caucasian                        Peters U        *Hum Genet*          2012   [12](#cas13391-bib-0012){ref-type="ref"}
  rs10774214     12p13.32     *CCND2*                                  1.17         3.06 × 10(−8)    East Asian and European          Jia WH          *Nat Genet*          2013   [13](#cas13391-bib-0013){ref-type="ref"}
  rs2423279      20p12.3      *HAO1, PLCB1*                            1.14         6.64 × 10(−9)    East Asian and European          Jia WH          *Nat Genet*          2013   [13](#cas13391-bib-0013){ref-type="ref"}
  rs647161       5q31.1       *PITX1*                                  1.17         1.22 × 10(−10)   East Asian and European          Jia WH          *Nat Genet*          2013   [13](#cas13391-bib-0013){ref-type="ref"}
  rs3987         4q26         *NDST3*                                  1.36         4.02 × 10(−8)    Spanish                          Real LM         *PLos One*           2014   [14](#cas13391-bib-0014){ref-type="ref"}
  rs35509282     4q32.2       *FSTL5*                                  1.53         8.2 × 10(−9)     Ashkenazi Jews and Europeans     Schmit SL       *Carcinogenesis*     2014   [15](#cas13391-bib-0015){ref-type="ref"}
  rs12241008     10q25        *VTI1A*                                  1.19         1.4 × 10(−9)     European, African and Japanese   Wang H          *Nat Commun*         2014   [16](#cas13391-bib-0016){ref-type="ref"}
  rs1035209      10p24.2      *MRP2*                                   1.13         4.54 × 10(−11)   East Asians in our European      Whiffin N       *Hum Mol Genet*      2014   [17](#cas13391-bib-0017){ref-type="ref"}
  rs3217810      12p13.32     *CCND2*                                  1.19         2.16 × 10(−10)   East Asians in our European      Whiffin N       *Hum Mol Genet*      2014   [17](#cas13391-bib-0017){ref-type="ref"}
  rs10911251     1q25.3       *LAMC1*                                  1.09         1.75 × 10(−8)    East Asians in our European      Whiffin N       *Hum Mol Genet*      2014   [17](#cas13391-bib-0017){ref-type="ref"}
  rs7229639      18q21.1      *SMAD7*                                  1.22         2.93 × 10(−11)   East Asians                      Zhang B         *Int J Cancer*       2014   [18](#cas13391-bib-0018){ref-type="ref"}
  rs704017       10q22.3      *ZMIZ1‐AS1*                              1.1          2.07 × 10(−8)    East Asians                      Zhang B         *Nat Genet*          2014   [18](#cas13391-bib-0018){ref-type="ref"}
  rs11196172     10q25.2      *TCF7L2*                                 1.14         1.04 × 10(−12)   East Asians                      Zhang B         *Nat Genet*          2014   [18](#cas13391-bib-0018){ref-type="ref"}
  rs1535         11q12.2      *FADS2*                                  1.15         8.21 × 10(−20)   East Asians                      Zhang B         *Nat Genet*          2014   [18](#cas13391-bib-0018){ref-type="ref"}
  rs174537       11q12.2      *MYRF*                                   1.16         9.22 × 10(−21)   East Asians                      Zhang B         *Nat Genet*          2014   [18](#cas13391-bib-0018){ref-type="ref"}
  rs174550       11q12.2      *FADS1*                                  1.15         1.58 × 10(−19)   East Asians                      Zhang B         *Nat Genet*          2014   [18](#cas13391-bib-0018){ref-type="ref"}
  rs4246215      11q12.2      *FEN1*                                   1.15         7.65 × 10(−20)   East Asians                      Zhang B         *Nat Genet*          2014   [18](#cas13391-bib-0018){ref-type="ref"}
  rs10849432     12p13.31     *CD9*                                    1.14         5.81 × 10(−10)   East Asians                      Zhang B         *Nat Genet*          2014   [18](#cas13391-bib-0018){ref-type="ref"}
  rs12603526     17p13.3      *NXN*                                    1.1          3.42 × 10(−8)    East Asians                      Zhang B         *Nat Genet*          2014   [18](#cas13391-bib-0018){ref-type="ref"}
  rs1800469      19q13.2      *TGFB1*                                  1.09         1.17 × 10(−8)    East Asians                      Zhang B         *Nat Genet*          2014   [18](#cas13391-bib-0018){ref-type="ref"}
  rs2241714      19q13.2      *B9D2*                                   1.09         1.36 × 10(−8)    East Asians                      Zhang B         *Nat Genet*          2014   [18](#cas13391-bib-0018){ref-type="ref"}
  rs10904849     10p13        *CUBN*                                   1.14         7.01 × 10(−8)    European                         Al‐Tassan NA    *Sci Rep*            2015   [19](#cas13391-bib-0019){ref-type="ref"}
  rs17836917     17q12        *MYO1D, CCL8, CCL13*                     0.75         4.55 × 10(−8)    Han Chinese                      Jiang K         *Oncotarget*         2015   [20](#cas13391-bib-0020){ref-type="ref"}
  rs12522693     5q23.3       *HINT1*                                  1.31         2.08 × 10(−8)    Han Chinese                      Jiang K         *Oncotarget*         2015   [20](#cas13391-bib-0020){ref-type="ref"}
  rs17094983     14q23.1      *--*                                     0.87         2.5 × 10(−10)    African                          Lemire M        *Hum Genet*          2015   [21](#cas13391-bib-0021){ref-type="ref"}
  rs16941835     16q24.1      *RP11‐58A18*                             1.15         5.06 × 10(−8)    African                          Lemire M        *Hum Genet*          2015   [21](#cas13391-bib-0021){ref-type="ref"}
  rs72647484     1q36.2       *CDC42, WNT4*                            1.21         1.21 × 10(−8)    African                          Lemire M        *Hum Genet*          2015   [21](#cas13391-bib-0021){ref-type="ref"}
  rs1119016410   10p24.1      *SLC25A28, ENTPD7, COX15, CUTC, ABCC2*   1.09         4.0 × 10(−8)     European and Asian               Schumacher FR   *Nat Commun*         2015   [22](#cas13391-bib-0022){ref-type="ref"}
  rs318450412    12q24.12     *SH2B3*                                  1.09         1.7 × 10(−8)     European and Asian               Schumacher FR   *Nat Commun*         2015   [22](#cas13391-bib-0022){ref-type="ref"}
  rs7320812012   12q24.22     *NOS1*                                   1.16         2.8 × 10(−8)     European and Asian               Schumacher FR   *Nat Commun*         2015   [22](#cas13391-bib-0022){ref-type="ref"}
  rs606682520    20q13.13     *PREX1*                                  1.09         4.4 × 10(−9)     European and Asian               Schumacher FR   *Nat Commun*         2015   [22](#cas13391-bib-0022){ref-type="ref"}
  rs8124813      3p14.1       *LRIG1*                                  1.09         2.0 × 10(−8)     European and Asian               Schumacher FR   *Nat Commun*         2015   [22](#cas13391-bib-0022){ref-type="ref"}
  rs35360328     3p22.1       *CTNNB1*                                 1.14         3.1 × 10(−9)     European and Asian               Schumacher FR   *Nat Commun*         2015   [22](#cas13391-bib-0022){ref-type="ref"}
  rs4711689      6p21.1       *TFEB*                                   1.11         3.9 × 10(−8)     East Asian                       Zeng C          *Gastroenterology*   2016   [23](#cas13391-bib-0023){ref-type="ref"}
  rs2450115      8q23.3       *EIF3H*                                  1.12         1.2 × 10(−12)    East Asian                       Zeng C          *Gastroenterology*   2016   [23](#cas13391-bib-0023){ref-type="ref"}
  rs6469656      8q23.3       *EIF3H*                                  1.11         2.0 × 10(−11)    East Asian                       Zeng C          *Gastroenterology*   2016   [23](#cas13391-bib-0023){ref-type="ref"}
  rs4919687      10q24.3      *CYP17A1*                                1.14         7.8 × 10(−12)    East Asian                       Zeng C          *Gastroenterology*   2016   [23](#cas13391-bib-0023){ref-type="ref"}
  rs11064437     12p13.3      *SPSB2*                                  1.12         4.5 × 10(−11)    East Asian                       Zeng C          *Gastroenterology*   2016   [23](#cas13391-bib-0023){ref-type="ref"}
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As for the Japanese population, several SNP‐based GWAS have been performed for CRC. Matsuo *et al*.[25](#cas13391-bib-0025){ref-type="ref"} performed a case‐control study using 481 cases and 962 controls and report an association between CRC and rs6893267 at 8q24. Furthermore, Cui *et al*.[9](#cas13391-bib-0009){ref-type="ref"} performed GWAS using 1583 Japanese CRC cases and 1898 controls and replication analyses using a total of 4809 CRC cases and 2973 controls, including 225 Korean subjects with distal colon cancer and 377 controls. They found an association between CRC and a known carcinogenic SNP at 8q24 and an association between distal CRC and rs7758229 in intron 5 of SLC22A3 at 6q26.[9](#cas13391-bib-0009){ref-type="ref"} Zhang *et al*.[26](#cas13391-bib-0026){ref-type="ref"} performed a case‐control study and reported that microsomal glutathione S‐transferase 1 (MGST1) gene polymorphisms had an association with CRC risk (OR = 1.682, *P *= 0.004) among the Han Chinese. However, the molecular biological mechanisms by which these SNP are involved in colorectal carcinogenesis remain unclear.

Using a case‐control study on 1511 CRC cases and 2098 controls, we previously reported that the risk allele of rs6983267 in 8q24 is associated with CRC, especially in diabetes mellitus patients.[27](#cas13391-bib-0027){ref-type="ref"} However, these SNPs, except for those in 8q24, have not been defined as the regulating polymorphisms of colorectal carcinogenesis beyond racial differences. To find the responsible host genetic factors, we designed an SNP‐based GWAS to identify SNP associated with susceptibility to morbidity from CRC in a pure Japanese population.[28](#cas13391-bib-0028){ref-type="ref"} We performed a multistage genome‐wide association study in Japanese individuals, with a total of 1846 cases and 2675 controls, to identify disease susceptibility SNP.

Materials and Methods {#cas13391-sec-0002}
=====================

Study samples {#cas13391-sec-0003}
-------------

We collected peripheral blood samples from nine collaborating institutes and hospitals for this project investigating the genetic risk factors of CRC cases. Newly diagnosed CRC cases were identified in eight hospitals (Kyushu University Beppu Hospital \[Beppu, Japan\], Kitazato University \[Kanagawa, Japan\], National Cancer Center Hospital \[Tokyo, Japan\], Northern Yokohama Hospital Showa University \[Kanagawa, Japan\], National Defense Medical College Hospital \[Saitama, Japan\], Tokyo Medical and Dental University Hospital \[Tokyo, Japan\], Mie University Hospital \[Mie, Japan\] and Takano Hospital \[Kumamoto, Japan\]) from 2000 to 2007. Controls without a prior history of CRC at the time of enrollment were also recruited from those hospitals. All controls were enrolled after having a colonoscopy to ensure that they had no disease. All participants provided documented informed content. The study protocol was reviewed and approved by each institute. We included 1846 cases and 2675 controls into the GWAS study. The average age of CRC patients was 61.9 ± 11.0 years, and that of controls was 59.8 ± 15.0 years. Age and gender details for each phase are shown in Table [S1](#cas13391-sup-0001){ref-type="supplementary-material"}. All cases and controls were of East Asian ancestry and from Japan.

Extraction of genomic DNA and PCR of markers {#cas13391-sec-0004}
--------------------------------------------

Genomic DNA was extracted from samples using conventional methodologies and quantified using PicoGreen (Invitrogen, Carlsbad, CA, USA). PCR was done using GeneAmp PCR System 9700 (Applied Biosystems, Carlsbad, CA, USA). Genotyping was done using the ABI 3100 Genetic Analyzer (Applied Biosystems) and analyses and assignment of marker alleles were done with the GENOTYPER programs (Applied Biosystems). Information on SNP was obtained from the dbSNP database (<http://www.ncbi.nlm.nih.gov/SNP/index.html>).

Genotyping {#cas13391-sec-0005}
----------

In phase 1, the genotyping of the 577 CRC cases and 571 controls was carried out using the Affymetrix GeneChip Human Mapping 500K Array Set according to the manufacturer\'s protocols. The equal number of patient and control samples enabled us to analyze the genotype and phenotype independently.

In phase 2.1 (fast‐track second screening), among the whole array of SNP, we focused on the highest‐ranked 100 SNP. Among those 100 SNP, we excluded SNP with a minor allele frequency (MAF) \<0.1 and selected TagSNP to avoiding overlapping and allelic imbalance, thus totaling 62 SNP that were confirmed by PCR in phase 2.1 by screening with a subset of 1181 cases and 1617 controls.

In phase 2.2 (full second screening), 480 CRC and 480 control samples were genotyped at the 1536 best SNP (allelic *P* \< 0.013) using the Illumina GoldenGate Assay. When multiple SNP displayed strong linkage disequilibrium (LD) with each other (r2 \> 0.8), the most closely associated SNP was chosen to avoid redundancy during the selection of the 1536 SNP. The samples with a genotype call rate \<0.98 and SNP with a call rate \<0.98, in Hardy--Weinberg disequilibrium (*P *\< 1.0 × 10^−4^) in the controls, or with a MAF \<0.05 were excluded from the association analysis.

For the 21 SNP that showed an allelic *P *\< 0.01 in phase 2.2, genotyping with the TaqMan method in 789 CRC cases and 1624 controls was performed in phase 3.

Statistical analysis {#cas13391-sec-0006}
--------------------

Genotype data cleaning and pairwise identity‐by‐descent (IBD) analysis were carried out using the PLINK software (version 1.06). We used the Haploview software (v3.2) to establish the LD structure on chromosome 10p14.

Results {#cas13391-sec-0007}
=======

An overview of the current study design is shown in Figure [1](#cas13391-fig-0001){ref-type="fig"}. The genome‐wide association study was carried out using the Affymetrix GeneChip Human Mapping 500K Array Set. In phase 1, we genotyped 500 568 tagSNP in 577 individuals with CRC and 571 controls using the Bayesian robust linear model with Mahalanobis (BRLMM) algorithm (<http://media.affymetrix.com/support/technical/whitepapers/brlmm_whitepaper.pdf>). Samples with a genotype call rate \<0.94 for either the NspI or StyI GeneChip SNP were removed from analysis. To detect duplicate samples, relatives and DNA‐contaminated samples, pairwise IBD estimation was carried out. After applying the strict quality control criteria described above, genotype data for 529 cases and 521 controls were chosen for analysis. SNP were removed from the analysis if they had a call rate of less than 0.95, showed a difference in call rate of more than 0.03 between CRC and controls, displayed Hardy--Weinberg disequilibrium (*P *\< 1.0 × 10^−6^) in the control group, or had a MAF \<0.10. SNP that were not selected in the updated GeneChip SNP5.0 (Affymetrix) were also excluded. After these exclusions, 280 972 SNP remained in the first stage. Figure [2](#cas13391-fig-0002){ref-type="fig"}a shows a Manhattan plot of these data. The genomic inflation factor based on the median χ^2^‐value was 1.100 in this genome‐wide association analysis (Fig. [2](#cas13391-fig-0002){ref-type="fig"}b), implying that there was no systematic increase of false positives owing to population stratification or any other form of bias. The strongest associations identified in phase 1 were found at the polymorphic sites rs13000465 (*P *= 5.16 × 10^−5^) on chromosome 2 and equally at rs7912831 (*P *= 6.57 × 10^−5^) on chromosome 10.

![The complete design of the genome‐wide association study. In phase 1, 577 patients with colorectal cancer (CRC) and 571 controls were genotyped for 500 568 single nucleotide polymorphisms (SNP) with Affymetrix 500 K chip sets. Two additional rounds of screening using the Illumina GoldenGate Assay (1536 SNP for phase 2.2) and TaqMan Assay (21 SNP for phase 3) were performed to identify significant SNP.](CAS-108-2239-g001){#cas13391-fig-0001}

![(a) Manhattan plots from the phase 1 genome‐wide association results. *P*‐values (−log10 *P*,*y*‐axis) are plotted against their respective chromosomal positions (*x*‐axis). Each chromosome is depicted in alternating blue and red. (b) Log quantile‐quantile *P*‐values between the expected (theoretical) *P*‐value and the observed *P*‐value. The genomic inflation factor (based on median χ^2^) is 1.10. If we set the odds ratio of the CRC‐related genotype as 1.4 and the allelic frequency in the control as 0.2, it will be located at the 36th quantile by the *P*‐value distribution. If we set the odds ratio of the CRC‐related genotype as 1.4 and the allelic frequency in the control as 0.4, it will be located at the 350th. If we set the odds ratio of the CRC‐related genotype as 1.2 and the allelic frequency in the control as 0.2, it will be located in greater than the 1000th, and the genotype will be difficult to determine.](CAS-108-2239-g002){#cas13391-fig-0002}

In phase 2.1, we focused on the 100 highest‐ranked SNP among the whole set of SNP. Among these 100 SNP, 62 SNP were confirmed by PCR after screening with a subset of 1181 cases and 1617 controls (Table [2](#cas13391-tbl-0002){ref-type="table-wrap"}). We confirmed the susceptibility of 4 SNP (rs13000465, rs7597875, rs7912831 and rs234588) to morbidity from CRC. Eventually, we identified the colorectal cancer susceptibility locus rs7912831 on chromosome 10p14 (*P *= 9.31E−08) (Table [2](#cas13391-tbl-0002){ref-type="table-wrap"}). Then, we proceeded to the phase 2.2 full screening and genotyped 480 CRC cases and 480 controls using the Illumina GoldenGate Assay for the top‐ranking 1536 SNP. A total of 21 SNP were identified in phase 2.2, including rs7912831 on chromosome 10p14.

###### 

Fast tracked second screening (phase 2.1) of single nucleotide polymorphisms (SNP) related to colorectal cancer

  Chromosome   SNP          Phase 1    Phase 2.1   First PCR   Second PCR   Total screening
  ------------ ------------ ---------- ----------- ----------- ------------ -----------------
  1            rs325914     4.86E−05   8.08E−01                             
  1            rs1510310    1.24E−04   5.82E−01                             
  1            rs1442459    4.32E−05   8.54E−01                             
  1            rs6692131    1.24E−04   2.75E−01                             
  2            rs7586098    2.25E−04   4.17E−01                             
  2            rs10178331   2.63E−05   7.25E−01                             
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For the 21 SNP that showed an allelic *P *\< 0.01 in phase 2, genotyping with the TaqMan method in 789 CRC cases and 1624 controls was performed in phase 3. The average SNP call rate of these 21 SNP was 0.998. We identified 4 SNP (rs7912831, rs4749812, rs7898455 and rs10905453) with an allelic *P* \< 0.05 on chromosome 10p14. As depicted in Figure [3](#cas13391-fig-0003){ref-type="fig"}, these SNP are within a region of fairly extensive LD consisting of a 500‐kb block on chromosome 10p14, which maps within 55 kb to the SNP rs10795668 reported by Tomlinson *et al*.[2](#cas13391-bib-0002){ref-type="ref"} This chromosomal region has already been reported to contain polymorphic sites; however, the current study is the first to report that variants at these specific polymorphic sites are associated with susceptibility to CRC. The final findings of our GWAS in Japanese CRC cases are shown in Table [3](#cas13391-tbl-0003){ref-type="table-wrap"}.

![Linkage disequilibrium (LD) structure at 10p14. The polymorphic site rs7912831 is depicted in an LD block of 500 kb where there are coding and non‐coding genes, such as non‐coding RNA and micro RNA. The SNP rs10795668, which has been previously reported by Tomlinson *et al*., is located close to rs7912831. Data were analyzed using Haploview software (v3.2)](CAS-108-2239-g003){#cas13391-fig-0003}

###### 

Final Findings of genome‐wide association studies in Japanese colorectal cancer cases

  Chromosome   SNP          Position   Phase 1   Phase 2.2   Phase 3   Combined   Odds ratio (95% CI)                                                                
  ------------ ------------ ---------- --------- ----------- --------- ---------- --------------------- -------- ------ ------ -------- ------ ------ -------------- -------------------
  10p14        rs7912831    8771261    0.60      0.53        0.00045   0.62       0.55                  0.0030   0.60   0.56   0.0035   0.61   0.55   0.0000000931   1.27 (1.16--1.39)
  10p14        rs4749812    8777570    0.61      0.53        0.00020   0.62       0.55                  0.0030   0.60   0.56   0.0046   0.61   0.55   0.0000000721   1.27 (1.17--1.39)
  10p14        rs7898455    8778914    0.68      0.61        0.00045   068        0.62                  0.0085   0.67   0.63   0.0027   0.68   0.62   0.000000155    1.28 (1.17--1.40)
  10p14        rs10905453   8784027    0.25      0.20        0.00972   0.25       0.20                  0.0082   0.25   0.21   0.0040   0.25   0.21   0.00000501     1.27 (1.15--1.41)

SNP, single nucleotide polymorphisms.
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Discussion {#cas13391-sec-0008}
==========

In this study, we identified 4 SNP that are significantly associated with morbidity from CRC at the 10p14 locus. These novel SNP are close to the variants on 10p14 described by Tomlinson *et al*.[1](#cas13391-bib-0001){ref-type="ref"} These independent whole genome‐wide association studies both found loci on 10p14 to be commonly associated with CRC. We consider this 10p14 locus to be a significant region of CRC susceptibility because it was identified in multiple studies in more than one race, including European and Japanese populations.[29](#cas13391-bib-0029){ref-type="ref"}, [30](#cas13391-bib-0030){ref-type="ref"} Recently, a significant interaction between an SNP at 10p14 (rs4143094) and processed meat consumption was also reported in CRC patients.[31](#cas13391-bib-0031){ref-type="ref"}

We performed data mining for genes that exist in this susceptibility locus in order to investigate the mechanism by which these SNP are connected to the causes of CRC. No genes, including noncoding RNA, were found in the susceptibility locus identified in the current study using the online human genome database (UCSC Genome Bioinformatics \[<http://genome.ucsc.edu/>\]) (Fig. [S1](#cas13391-sup-0002){ref-type="supplementary-material"}). The genes nearest to our susceptibility locus at 10p14 are GATA3 and CUGBP2. However, no significant correlations between our SNP and the expression of these genes were found by the combined SNP and cDNA expression arrays. We also sought to find new transcripts related to colorectal carcinogenesis at the 10p14 locus. First, we performed a RACE assay for each region where the SNP exist using total RNA extracted from CRC cell lines (Fig. [S2](#cas13391-sup-0002){ref-type="supplementary-material"}), but we could not find any transcripts around all 4 SNP. Second, we found a sequence homologous to mmu‐mir‐1981, which is a murine micro RNA, just beside rs10905453. However, no transcript was found with northern blotting (Fig. [S3](#cas13391-sup-0002){ref-type="supplementary-material"}). Moreover, we also did not find new protein‐coding or RNA genes in the susceptibility region using mRNA whole‐transcriptome analysis of 25 CRC cancer tissues. We could not find any functional genes around carcinogenic SNP in 10p14 in this study. Few reports have demonstrated the mechanism by which an SNP regulates the expression of genes or noncoding RNA to promote carcinogenesis and the development of CRC, but further study is warranted.

The mechanisms of CRC carcinogenesis caused by carcinogenic SNP, including the most common SNP rs6983267 at 8q24, are not well known because these SNP do not exist in coding regions. Tuupanen *et al*.[32](#cas13391-bib-0032){ref-type="ref"} report that the risk allele of rs6983267 is associated with microsatellite‐stable cancer, and propose that the underlying germ line genetic defect in 8q24 was a target in the somatic evolution of CRC. Interestingly, they also report that the risk allele G shows a copy number increase during CRC development and that rs6983267 affected a binding site for the Wnt‐regulated transcription factor TCF4/LEF1, which leads to the enhancement of *MYC* transcription *in vitro* and *in vivo*.[33](#cas13391-bib-0033){ref-type="ref"}, [34](#cas13391-bib-0034){ref-type="ref"} The abundant expression of *MYC* contributes to carcinogenesis and progression of CRC.[27](#cas13391-bib-0027){ref-type="ref"}, [34](#cas13391-bib-0034){ref-type="ref"}, [35](#cas13391-bib-0035){ref-type="ref"}, [36](#cas13391-bib-0036){ref-type="ref"}

We consider that further analysis of such loci will enable us to understand the unknown mechanisms of colorectal carcinogenesis, including discovering new genes or noncoding RNA. For example, we reported that an SNP in miR‐146a targeting EGFR and IRAK1 is associated with the prognosis of gastric cancer patients.[37](#cas13391-bib-0037){ref-type="ref"} As the underlying basis of the association identified at 10p14 is presently unclear, there are no clues to explain how this region is involved in morbidity from CRC. Our data reveal that 10p14 is a colorectal cancer susceptible region for more than one racial subgroup, but further studies are warranted to find the mechanistic relationship between 10p14 and colorectal carcinogenesis.

In conclusion, using a multistage GWAS in Japanese individuals, we identified a significant genome‐wide level of association for 4 SNP on chromosome 10p14 associated with the onset of CRC.
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**Table S1.** Demographic data of patients and controls in this study.

###### 

Click here for additional data file.

###### 

**Fig. S1.** Data mining for genes which exist in oncogenic susceptibility locus using online database.

**Fig. S2.** Four primer sets, sandwiching 4 single nucleotide polymorphisms at 10p14 were designed for qRT‐PCR assay.

**Fig. S3.** Exploration of transcripts in 10p14 region with northern blotting.
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Click here for additional data file.
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